NM_005932.4:c.2045G>A

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBS1_Supporting

The NM_005932.4(MIPEP):​c.2045G>A​(p.Gly682Asp) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00076 in 1,607,416 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/24 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.0010 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00073 ( 0 hom. )

Consequence

MIPEP
NM_005932.4 missense, splice_region

Scores

5
14
Splicing: ADA: 0.04189
2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:5

Conservation

PhyloP100: 5.71

Publications

4 publications found
Variant links:
Genes affected
MIPEP (HGNC:7104): (mitochondrial intermediate peptidase) The product of this gene performs the final step in processing a specific class of nuclear-encoded proteins targeted to the mitochondrial matrix or inner membrane. This protein is primarily involved in the maturation of oxidative phosphorylation (OXPHOS)-related proteins. This gene may contribute to the functional effects of frataxin deficiency and the clinical manifestations of Friedreich ataxia. [provided by RefSeq, Jul 2008]
MIPEP Gene-Disease associations (from GenCC):
  • lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Broad Center for Mendelian Genomics
  • mitochondrial disease
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.13435099).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00103 (157/152178) while in subpopulation NFE AF = 0.0019 (129/68034). AF 95% confidence interval is 0.00163. There are 0 homozygotes in GnomAd4. There are 64 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MIPEPNM_005932.4 linkc.2045G>A p.Gly682Asp missense_variant, splice_region_variant Exon 19 of 19 ENST00000382172.4 NP_005923.3 Q99797
MIPEPXM_011535097.3 linkc.1859G>A p.Gly620Asp missense_variant, splice_region_variant Exon 19 of 19 XP_011533399.1
LOC105370113XR_007063722.1 linkn.651+1168C>T intron_variant Intron 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MIPEPENST00000382172.4 linkc.2045G>A p.Gly682Asp missense_variant, splice_region_variant Exon 19 of 19 1 NM_005932.4 ENSP00000371607.3 Q99797

Frequencies

GnomAD3 genomes
AF:
0.00103
AC:
157
AN:
152178
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000848
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00190
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.000697
AC:
171
AN:
245244
AF XY:
0.000671
show subpopulations
Gnomad AFR exome
AF:
0.000190
Gnomad AMR exome
AF:
0.000377
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00116
Gnomad NFE exome
AF:
0.00116
Gnomad OTH exome
AF:
0.000332
GnomAD4 exome
AF:
0.000732
AC:
1065
AN:
1455238
Hom.:
0
Cov.:
28
AF XY:
0.000761
AC XY:
551
AN XY:
724024
show subpopulations
African (AFR)
AF:
0.0000905
AC:
3
AN:
33156
American (AMR)
AF:
0.000403
AC:
18
AN:
44684
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26092
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39294
South Asian (SAS)
AF:
0.0000117
AC:
1
AN:
85570
European-Finnish (FIN)
AF:
0.000771
AC:
41
AN:
53198
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5762
European-Non Finnish (NFE)
AF:
0.000884
AC:
979
AN:
1107368
Other (OTH)
AF:
0.000333
AC:
20
AN:
60114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
48
96
144
192
240
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00103
AC:
157
AN:
152178
Hom.:
0
Cov.:
33
AF XY:
0.000861
AC XY:
64
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.000169
AC:
7
AN:
41428
American (AMR)
AF:
0.000655
AC:
10
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5204
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.000848
AC:
9
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00190
AC:
129
AN:
68034
Other (OTH)
AF:
0.000956
AC:
2
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
9
18
26
35
44
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00138
Hom.:
0
Bravo
AF:
0.000801
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00128
AC:
11
ExAC
AF:
0.000585
AC:
71
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome Uncertain:2
Aug 04, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 02, 2018
Baylor Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -

not provided Uncertain:2
Oct 16, 2020
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Jan 02, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 682 of the MIPEP protein (p.Gly682Asp). This variant is present in population databases (rs150308123, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with MIPEP-related conditions. ClinVar contains an entry for this variant (Variation ID: 392943). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not specified Uncertain:1
May 02, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: MIPEP c.2045G>A (p.Gly682Asp) results in a non-conservative amino acid change located in the Peptidase M3A/M3B catalytic domain (IPR001567) of the encoded protein sequence, in the first nucleotide of exon 19 adjacent to the intron 18 / exon 19 3' splice acceptor site. Three of five in-silico tools predict a benign effect of the variant on protein function. Several computational tools predict a significant impact on normal splicing: Four predict the variant abolishes a cryptic 5' donor site. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.0007 in 245244 control chromosomes. To our knowledge, no occurrence of c.2045G>A in individuals affected with Lethal Left Ventricular Non-Compaction Delay Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 392943). Based on the evidence outlined above, the variant was classified as uncertain significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.40
CADD
Uncertain
23
DANN
Benign
0.53
DEOGEN2
Benign
0.024
T
Eigen
Uncertain
0.47
Eigen_PC
Uncertain
0.49
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.91
D
M_CAP
Benign
0.017
T
MetaRNN
Benign
0.13
T
MetaSVM
Benign
-0.71
T
MutationAssessor
Benign
0.030
N
PhyloP100
5.7
PrimateAI
Uncertain
0.68
T
PROVEAN
Benign
1.1
N
REVEL
Benign
0.27
Sift
Benign
0.90
T
Sift4G
Benign
0.97
T
Polyphen
0.0
B
Vest4
0.84
MVP
0.57
MPC
0.12
ClinPred
0.032
T
GERP RS
5.4
Varity_R
0.26
gMVP
0.65
Mutation Taster
=48/52
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.042
dbscSNV1_RF
Benign
0.45
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150308123; hg19: chr13-24304584; COSMIC: COSV108239730; API